<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MS-275 is a synthetic <z:chebi fb="0" ids="28179">benzamide</z:chebi> derivative of the <z:chebi fb="0" ids="15358">histone</z:chebi> deacetylase inhibitor and is currently in phase I/II clinical trials </plain></SENT>
<SENT sid="1" pm="."><plain>Many reports have shown that the anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> activity of MS-275 in several types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is mainly attributable to its capacity to induce the apoptotic <z:hpo ids='HP_0011420'>death</z:hpo> of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>It remains unclear if autophagy is involved in MS-275 treatment of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we first show that MS-275 induces human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell HCT116 autophagy as well as <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Short-term treatment (24h) induced HCT116 cells to undergo autophagy with dependence on intracellular reactive oxygen species production and ERK activation </plain></SENT>
<SENT sid="5" pm="."><plain>The activated reactive oxygen species/ERK signal promoted Atg7 protein expression, which triggered MS-275-induced <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell autophagy </plain></SENT>
<SENT sid="6" pm="."><plain>However, after prolonged treatment with MS-275 (over 48h), autophagic cells turned apoptotic, which was also dependent on reactive oxygen species generation </plain></SENT>
<SENT sid="7" pm="."><plain>Interestingly, we found that p38 MAP kinase played a vital role in the switch from autophagy to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in MS-275-induced human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells </plain></SENT>
<SENT sid="8" pm="."><plain>High expression of p38 induced cell autophagy, but low expression resulted in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, observations in vivo are strongly consistent with the in vitro results </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore, these findings extend our understanding of the action of MS-275 in inducing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell <z:hpo ids='HP_0011420'>death</z:hpo> and suggest that it may be a promising clinical chemotherapeutic agent with multiple effects </plain></SENT>
</text></document>